Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionality is currently unavailable.

Chandraditya Chakraborty, Ph.D.

Title
Institution
Department
Address
Phone

Biography
Chittaranjan National Cancer Institute, Kolkata, IndiaPhD11/2017Cancer Genetics

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Xu Y, Fulciniti M, Samur MK, Ho M, Deng S, Liu L, Wen K, Yu T, Chyra Z, Dereibal S, Zhang L, Yao Y, Chakraborty C, Morelli E, Li N, Lopez MA, Perini T, Mu S, An G, Alonso R, Bianchi G, Tai YT, Anderson KC, Qiu L, Munshi NC. YWHAE/14-3-3e expression impacts the protein load, contributing to proteasome inhibitor sensitivity in multiple myeloma. Blood. 2020 Jul 23; 136(4):468-479. PMID: 32187357.
    Citations:    Fields:    
  2. Liao C, Zhao J, Kumar S, Chakraborty C, Talluri S, Munshi NC, Shammas MA. RAD51 Inhibitor Reverses Etoposide-Induced Genomic Toxicity and Instability in Esophageal Adenocarcinoma Cells. Arch Clin Toxicol (Middlet). 2020; 2(1):3-9. PMID: 32968740.
    Citations:    
  3. Alagpulinsa DA, Kumar S, Talluri S, Nanjappa P, Buon L, Chakraborty C, Samur MK, Szalat R, Shammas MA, Munshi NC. Amplification and overexpression of E2 ubiquitin conjugase UBE2T promotes homologous recombination in multiple myeloma. Blood Adv. 2019 12 10; 3(23):3968-3972. PMID: 31805191.
    Citations:    Fields:    Translation:Humans
  4. Chakraborty C, Mitra S, Roychowdhury A, Samadder S, Dutta S, Roy A, Das P, Mandal RK, Sharp TV, Roychoudhury S, Panda CK. Deregulation of LIMD1-VHL-HIF-1a-VEGF pathway is associated with different stages of cervical cancer. Biochem J. 2018 05 31; 475(10):1793-1806. PMID: 29654110.
    Citations: 3     Fields:    Translation:HumansCells
  5. Chakraborty C, Samadder S, Roychowdhury A, Roy A, Das P, Mandal RK, Roychoudhury S, Panda CK. Activation of Wnt-ß-catenin pathway in basal-parabasal layers of normal cervical epithelium comparable during development of uterine cervical carcinoma. Mol Cell Biochem. 2018 Jun; 443(1-2):121-130. PMID: 29079964.
    Citations:    Fields:    Translation:HumansCells
  6. Roychowdhury A, Samadder S, Das P, Mandloi S, Addya S, Chakraborty C, Basu PS, Mondal R, Roy A, Chakrabarti S, Roychoudhury S, Panda CK. Integrative genomic and network analysis identified novel genes associated with the development of advanced cervical squamous cell carcinoma. Biochim Biophys Acta Gen Subj. 2017 Jan; 1861(1 Pt A):2899-2911. PMID: 27641506.
    Citations: 3     Fields:    Translation:HumansCells
  7. Chakraborty C, Roychowdhury A, Samadder S, Roy A, Mandal RK, Basu P, Roychoudhury S, Panda CK. Association of P16-RBSP3 inactivation with phosphorylated RB1 overexpression in basal-parabasal layers of normal cervix unchanged during CACX development. Biochem J. 2016 10 01; 473(19):3221-36. PMID: 27458253.
    Citations: 2     Fields:    Translation:HumansCells
  8. Dutta S, Chakraborty C, Mandal RK, Basu P, Biswas J, Roychoudhury S, Panda CK. Persistent HPV16/18 infection in Indian women with the A-allele (rs6457617) of HLA-DQB1 and T-allele (rs16944) of IL-1ß -511 is associated with development of cervical carcinoma. Cancer Immunol Immunother. 2015 Jul; 64(7):843-51. PMID: 25893807.
    Citations: 7     Fields:    Translation:HumansCells
  9. Dutta S, Chakraborty C, Dutta AK, Mandal RK, Roychoudhury S, Basu P, Panda CK. Physical and methylation status of human papillomavirus 16 in asymptomatic cervical infections changes with malignant transformation. J Clin Pathol. 2015 Mar; 68(3):206-11. PMID: 25563334.
    Citations: 5     Fields:    Translation:HumansCells
  10. Chakraborty C, Dutta S, Mukherjee N, Samadder S, Roychowdhury A, Roy A, Mondal RK, Basu P, Roychoudhury S, Panda CK. Inactivation of PTCH1 is associated with the development of cervical carcinoma: clinical and prognostic implication. Tumour Biol. 2015 Feb; 36(2):1143-54. PMID: 25330948.
    Citations: 4     Fields:    Translation:HumansCells
  11. Mazumder Indra D, Singh RK, Mitra S, Dutta S, Chakraborty C, Basu PS, Mondal RK, Roychoudhury S, Panda CK. Genetic and epigenetic changes of HPV16 in cervical cancer differentially regulate E6/E7 expression and associate with disease progression. Gynecol Oncol. 2011 Dec; 123(3):597-604. PMID: 21911249.
    Citations: 23     Fields:    Translation:HumansCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Chakraborty's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (65)
Explore
_
Co-Authors (13)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.